Valuation

MEDMedifast Inc

StockNYSEUnited StatesConsumer staplesEU retail investors: available

+4.4% today · +12.1% over a year

No score: too little data.

Quality, Stability: among the weakest. No dividend.

Medifast Inc (MED) valuation against sector peers: P/B 0.8, free-cash-flow yield −2.6%, P/S 0.5.

Ratios vs sector

Medians of Consumer staples companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricMEDSector medianvs median
P/E—23.5 · n=71—
P/B0.82.2 · n=8363% below
P/S0.50.8 · n=8940% below
EV/EBIT—20.4 · n=67—
Free-cash-flow yield−2.6%5.2% · n=87149% below
Dividend yield0.00%1.73% · n=97100% below
Return on equity−20.7%10.8% · n=88291% below
Return on invested capital−29.3%8.6% · n=88441% below
Gross margin69.2%32.5% · n=95113% above
Net debt / EBITDA—1.74 · n=77—

Sector peers

The largest companies of the same sector and region.

WMTWalmart45.210.132.01.4%0.8%6/10
COSTCostco Wholesale51.213.239.12.0%0.5%8/10
KOCoca-Cola28.211.128.93.5%2.2%9/10
PGProcter & Gamble24.87.120.93.9%3.2%8/10
PMPhilip Morris28.2—20.64.5%3.1%10/10
PEPPepsiCo23.59.520.64.0%4.1%6/10
MOAltria Group15.6—13.37.2%5.7%10/10
MNSTMonster Beverage41.19.131.32.2%0.0%6/10
MDLZMondelez20.63.219.14.3%3.0%6/10
CLColgate-Palmolive37.9270.326.54.9%2.7%8/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Sep 2026 · filed 26 Oct 2026